Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.

The team, which included senior researchers in epidemiology, health economics and orthopaedic surgery, used routinely-collected hospital and primary care data from patients who had a knee replacement or a hip replacement in England, assessing over 10,000 patients for each procedure.

With healthcare budgets stretched, the provision of knee and hip replacements has come under increased pressure in the NHS. One result is that access to these surgeries has been restricted, and a number of clinical commissioning groups (CCGs) are currently limiting access based on patient's BMI and smoking status. In 2015, 22% of CCGs had a mandatory policy for knee and replacement regarding BMI, varying their cut-offs from a BMI of 30 to 40, and 4% of CCGs had mandatory policies requiring smoking cessation.

"Our findings, along with those from previous research, suggest that there is little evidence to support the rationing of knee and hip replacement based on individuals' BMI or smoking" said Ed Burn, DPhil student at the University of Oxford. "While there are many benefits from losing weight if overweight and stopping smoking, there seems to be little justification in limiting access to knee and hip replacement until such changes are made".

Previous research had already shown that BMI and smoking have little effect on patient reported outcomes after knee and hip replacement, but may be associated with a slight increase in the risk of post-operative complications.

Revision procedures are where implant components are removed, added, or exchanged. Revisions are an enduring risk, are more costly than primary procedures, and are associated with reductions in patient quality of life.

Funder

NIHR logo

Similar stories

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.